Abecma

New CEO to revive Bristol Myers’ new drugs | Pharma News

Bristol Myers’ new CEO aims to boost weak new drug launches

Anika Sharma

Bristol Myers Squibb (BMS) is addressing concerns about its underperforming new products, expressing confidence in their future success. The company’s ...

Bristol Myers Squibb, Cellares, CAR-T Therapy, Blood cancer, Abecma, Breyanzi, cell and gene therapy

Bristol Myers Squibb’s Bold Robotic Alliance with Cellares for Advanced CAR-T Production

Anika Sharma

In the realm of cutting-edge cell therapy, where innovation is the heartbeat and the promise of transformative treatments is the ...